Department of Anesthesiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Second Road, Yuexiu District, Guangzhou, Guangdong, 510080, P.R. China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
BMC Anesthesiol. 2022 Mar 16;22(1):71. doi: 10.1186/s12871-022-01599-4.
Rhomboid intercostal block (RIB) is a new regional anesthesia technique that provides postoperative analgesia for breast surgery and thoracoscopic surgery. The published papers are not yet fully integrated and do not adequately address the impact and safety of the RIB on postoperative pain.
The PubMed, Web of Science and Embase were searched from 2016 to 2021 for all available randomized controlled trials (RCTs) that evaluated the analgesic efficacy and safety of RIB after thoracic surgery and breast surgery. Random and fixed-effects meta-analytical models were used where indicated, and between-study heterogeneity was assessed. The primary outcome was Postoperative Numerical Rating Scale (NRS) scores of patients at rest recorded 0-1, 6-8, 24 h after surgery. The secondary outcomes included rate of postoperative nausea and vomiting (PONV), postoperative fentanyl consumption and presence of complications of the block.
From 81 records identified, four studies met our inclusion criteria, including 216 patients (RIB:108 patients; no block: 108 patients). In the primary outcome, RIB group showed significantly lower postoperative NRS at rest at first 0-1 h and 6-8 h (weighted mean difference [WMD] = -1.55; 95% confidence internal [CI] = -2.92 to -0.19; p < 0.05), (WMD = -0. 69; 95% CI = -1.29 to -0. 09; p < 0. 05). And there was no significant difference between groups in NRS at rest at 24 h (WMD = -0.78; 95% CI = -1.64 to -0.08; p = 0.77). Also, RIB group showed significantly lower postoperative NRS of breast surgery and thoracoscopic surgery at 0-1 h (WMD = -3.00; 95% CI = -3.13 to -2.87; p < 0.01), (WMD = -1.08; 95% CI = -1.98 to -0.18; p < 0.05). In the secondary outcome, the analysis also showed RIB group had significant lower of POVN rates (summary relative risk (RR) = 0.212;95%CI = 0.10 to 0.45; p < 0. 01) and the postoperative consumption of fentanyl (WMD = -57.52;95%CI = -106.03 to -9.02; p < 0. 05).
This review shows that RIB was more effective in controlling acute pain after breast surgery and thoracoscopic surgery than general analgesia. And it is a trend that RIB may be a kind of effective and safe nerve bock technology and it requires further studies.
菱形肋间阻滞(RIB)是一种新的区域麻醉技术,可为乳房手术和胸腔镜手术提供术后镇痛。已发表的论文尚未完全整合,也没有充分说明 RIB 对术后疼痛的影响和安全性。
检索了 2016 年至 2021 年期间在 PubMed、Web of Science 和 Embase 上发表的所有关于 RIB 对胸部手术和乳房手术后镇痛效果和安全性的随机对照试验(RCT)。需要时使用随机和固定效应荟萃分析模型,并评估了研究间的异质性。主要结局是术后 0-1、6-8 和 24 小时患者静息时的数字评分量表(NRS)评分。次要结局包括术后恶心和呕吐(PONV)发生率、术后芬太尼消耗量和阻滞并发症的发生情况。
从 81 条记录中,有 4 项研究符合纳入标准,包括 216 名患者(RIB:108 名患者;无阻滞:108 名患者)。在主要结局中,RIB 组在首次 0-1 小时和 6-8 小时的静息时术后 NRS 评分明显较低(加权均数差[WMD] = -1.55;95%置信区间[CI] = -2.92 至 -0.19;p < 0.05),(WMD = -0.69;95%CI = -1.29 至 -0.09;p < 0.05)。两组在 24 小时静息时的 NRS 评分无显著差异(WMD = -0.78;95%CI = -1.64 至 -0.08;p = 0.77)。此外,RIB 组在 0-1 小时时的乳房手术和胸腔镜手术后的静息时 NRS 评分明显较低(WMD = -3.00;95%CI = -3.13 至 -2.87;p < 0.01),(WMD = -1.08;95%CI = -1.98 至 -0.18;p < 0.05)。在次要结局中,分析还显示 RIB 组的 POVN 发生率显著降低(汇总相对风险[RR] = 0.212;95%CI = 0.10 至 0.45;p < 0.01)和术后芬太尼消耗量减少(WMD = -57.52;95%CI = -106.03 至 -9.02;p < 0.05)。
本综述表明,RIB 比一般镇痛更有效地控制乳房手术和胸腔镜手术后的急性疼痛。RIB 可能是一种有效且安全的神经阻滞技术,这是一种趋势,需要进一步研究。